Literature DB >> 8794305

Activity of purified hepatitis C virus protease NS3 on peptide substrates.

C Steinkühler1, A Urbani, L Tomei, G Biasiol, M Sardana, E Bianchi, A Pessi, R De Francesco.   

Abstract

The protease domain of the hepatitis C virus (HCV) protein NS3 was expressed in Escherichia coli, purified to homogeneity, and shown to be active on peptides derived from the sequence of the NS4A-NS4B junction. Experiments were carried out to optimize protease activity. Buffer requirements included the presence of detergent, glycerol, and dithiothreitol, pH between 7.5 and 8.5, and low ionic strength. C- and N-terminal deletion experiments defined a peptide spanning from the P6 to the P4' residue as a suitable substrate. Cleavage kinetics were subsequently measured by using decamer P6-P4' peptides corresponding to all intermolecular cleavage sites of the HCV polyprotein. The following order of cleavage efficiency, in terms of kcat/Km, was determined: NS5A-NS5B > NS4A-NS4B >> NS4B-NS5A. A 14-mer peptide containing residues 21 to 34 of the protease cofactor NS4A (Pep4A 21-34), when added in stoichiometric amounts, was shown to increase cleavage rates of all peptides, the largest effect (100-fold) being observed on the hydrolysis of the NS4B-NS5A decamer. From the kinetic analysis of cleavage data, we conclude that (i) primary structure is an important determinant of the efficiency with which each site is cleaved during polyprotein processing, (ii) slow cleavage of the NS4B-NS5A site in the absence of NS4A is due to low binding affinity of the enzyme for this site, and (iii) formation of a 1:1 complex between the protease and Pep4A 21-34 is sufficient and required for maximum activation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8794305      PMCID: PMC190711     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

1.  Proteolytic processing and membrane association of putative nonstructural proteins of hepatitis C virus.

Authors:  M Hijikata; H Mizushima; Y Tanji; Y Komoda; Y Hirowatari; T Akagi; N Kato; K Kimura; K Shimotohno
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-15       Impact factor: 11.205

2.  In vitro cleavage of hepatitis C virus polyprotein substrates by purified recombinant NS3 protease.

Authors:  E D D'Souza; K Grace; D V Sangar; D J Rowlands; B E Clarke
Journal:  J Gen Virol       Date:  1995-07       Impact factor: 3.891

3.  Peptide substrate cleavage specificity of the human cytomegalovirus protease.

Authors:  V V Sardana; J A Wolfgang; C A Veloski; W J Long; K LeGrow; B Wolanski; E A Emini; R L LaFemina
Journal:  J Biol Chem       Date:  1994-05-20       Impact factor: 5.157

4.  Two proteinase activities in HCV polypeptide expressed in insect cells using baculovirus vector.

Authors:  Y Hirowatari; M Hijikata; Y Tanji; H Nyunoya; H Mizushima; K Kimura; T Tanaka; N Kato; K Shimotohno
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

5.  Molecular model of the specificity pocket of the hepatitis C virus protease: implications for substrate recognition.

Authors:  E Pizzi; A Tramontano; L Tomei; N La Monica; C Failla; M Sardana; T Wood; R De Francesco
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

6.  NS3 is a serine protease required for processing of hepatitis C virus polyprotein.

Authors:  L Tomei; C Failla; E Santolini; R De Francesco; N La Monica
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

7.  Two distinct proteinase activities required for the processing of a putative nonstructural precursor protein of hepatitis C virus.

Authors:  M Hijikata; H Mizushima; T Akagi; S Mori; N Kakiuchi; N Kato; T Tanaka; K Kimura; K Shimotohno
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

8.  The hepatitis C virus encodes a serine protease involved in processing of the putative nonstructural proteins from the viral polyprotein precursor.

Authors:  M R Eckart; M Selby; F Masiarz; C Lee; K Berger; K Crawford; C Kuo; G Kuo; M Houghton; Q L Choo
Journal:  Biochem Biophys Res Commun       Date:  1993-04-30       Impact factor: 3.575

9.  A second hepatitis C virus-encoded proteinase.

Authors:  A Grakoui; D W McCourt; C Wychowski; S M Feinstone; C M Rice
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-15       Impact factor: 11.205

10.  In vitro activity of the herpes simplex virus type 1 protease with peptide substrates.

Authors:  C L DiIanni; C Mapelli; D A Drier; J Tsao; S Natarajan; D Riexinger; S M Festin; M Bolgar; G Yamanaka; S P Weinheimer
Journal:  J Biol Chem       Date:  1993-12-05       Impact factor: 5.157

View more
  29 in total

1.  Isolation and characterization of monoclonal antibodies that inhibit hepatitis C virus NS3 protease.

Authors:  T Ueno; S Misawa; Y Ohba; M Matsumoto; M Mizunuma; N Kasai; K Tsumoto; I Kumagai; H Hayashi
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

2.  Conformational changes in the NS3 protease from hepatitis C virus strain Bk monitored by limited proteolysis and mass spectrometry.

Authors:  S Orrù; F Dal Piaz; A Casbarra; G Biasiol; R De Francesco; C Steinkühler; P Pucci
Journal:  Protein Sci       Date:  1999-07       Impact factor: 6.725

3.  Probing the substrate specificity of hepatitis C virus NS3 serine protease by using synthetic peptides.

Authors:  R Zhang; J Durkin; W T Windsor; C McNemar; L Ramanathan; H V Le
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

4.  The effect of prime-site occupancy on the hepatitis C virus NS3 protease structure.

Authors:  Annarita Casbarra; Fabrizio Dal Piaz; Paolo Ingallinella; Stefania Orrù; Piero Pucci; Antonello Pessi; Elisabetta Bianchi
Journal:  Protein Sci       Date:  2002-09       Impact factor: 6.725

5.  Characterization of engineered hepatitis C virus NS3 protease inhibitors affinity selected from human pancreatic secretory trypsin inhibitor and minibody repertoires.

Authors:  N Dimasi; F Martin; C Volpari; M Brunetti; G Biasiol; S Altamura; R Cortese; R De Francesco; C Steinkühler; M Sollazzo
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

6.  Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF.

Authors:  Kui Li; Eileen Foy; Josephine C Ferreon; Mitsuyasu Nakamura; Allan C M Ferreon; Masanori Ikeda; Stuart C Ray; Michael Gale; Stanley M Lemon
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-14       Impact factor: 11.205

Review 7.  Protease inhibitors as antiviral agents.

Authors:  A K Patick; K E Potts
Journal:  Clin Microbiol Rev       Date:  1998-10       Impact factor: 26.132

8.  GB virus B and hepatitis C virus NS3 serine proteases share substrate specificity.

Authors:  E Scarselli; A Urbani; A Sbardellati; L Tomei; R De Francesco; C Traboni
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

9.  Bovine viral diarrhea virus NS3 serine proteinase: polyprotein cleavage sites, cofactor requirements, and molecular model of an enzyme essential for pestivirus replication.

Authors:  J Xu; E Mendez; P R Caron; C Lin; M A Murcko; M S Collett; C M Rice
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

10.  Selection of functional variants of the NS3-NS4A protease of hepatitis C virus by using chimeric sindbis viruses.

Authors:  G Filocamo; L Pacini; C Nardi; L Bartholomew; M Scaturro; P Delmastro; A Tramontano; R De Francesco; G Migliaccio
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.